Ecopetrol
EC
Petroleo Brasileiro SA Petrobras
PBR
Oracle
ORCL
Vale SA
VALE
Strategy
MSTR
US Stock MarketDetailed Quotes
NKGN NKGEN BIOTECH
- 0.544
- -0.087-13.80%
Trading Feb 18 10:39 ET
24.45MMarket Cap-0.14P/E (TTM)
0.630High0.500Low740.55KVolume0.620Open0.631Pre Close405.30KTurnover3.27%Turnover RatioLossP/E (Static)44.95MShares4.06052wk High-0.35P/B12.32MFloat Cap0.20352wk Low--Dividend TTM22.65MShs Float12.880Historical High--Div YieldTTM20.59%Amplitude0.203Historical Low0.547Avg Price1Lot Size
About NKGEN BIOTECH Company
NKGen Biotech, Inc. is a clinical-stage biotechnology company, which focuses on the development and commercialization of innovative autologous, allogeneic, and CAR-NK cell therapies utilizing a proprietary SNK platform. Its product candidates are based on a proprietary manufacturing and cryopreservation process which produces SNK cells that have high potency as defined by parameters such as cytotoxicity, cytokine production, and activating receptor expression. The company was founded by Sangwoo Park in 2017 and is headquartered in Santa Ana, CA.
Company Profile
SymbolNKGN
Company NameNKGEN BIOTECH
Listing DateOct 2, 2023
Founded2017
CEODr. Paul Y. Song, M.D.
MarketNASDAQ
Employees63
Fiscal Year Ends12-31
Address3001 Daimler Street
CitySanta Ana
ProvinceCalifornia
CountryUnited States of America
Zip Code92705
Phone1-949-396-6830
Websitehttp://www.nkgenbiotech.com
Company Executives
- Name
- Position
- Salary
- Dr. Paul Y. Song, M.D.
- Chief Executive Officer and Chairman of the Board
- 3.33M
- James A. Graf
- Interim Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Yong-Man Kim, PhD
- Chief Scientific Officer
- 809.26K
- Michael Klowden
- Director
- --
- Kathleen D. Scott
- Director
- --
- Dr. Marco Gottardis, PhD
- Director
- --
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.